GGrantIndex
← Search

DEVELOPING NEW CELL-MEDIATED IMMUNOTHERAPEUTIC STRATEGIES FOR NEUROENDOCRINE PROSTATE CANCER

$235,476FY2025Defense Health AgencyDOD

University Of California, Los Angeles

Investigators

View source on USAspending →
DEVELOPING NEW CELL-MEDIATED IMMUNOTHERAPEUTIC STRATEGIES FOR NEUROENDOCRINE PROSTATE CANCER · GrantIndex